These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33986804)

  • 1. E2F1 Maintains Gastric Cancer Stemness Properties by Regulating Stemness-Associated Genes.
    Fu Y; Hu C; Du P; Huang G
    J Oncol; 2021; 2021():6611327. PubMed ID: 33986804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F1 Facilitates the Proliferation and Stemness of Gastric Cancer Cells by Activating CDC25B Transcription and Modulating the MAPK Pathway.
    Liu M; Xu C; Cheng G; Chen Z; Pan X; Mei Y
    Biochem Genet; 2024 Jul; ():. PubMed ID: 38981987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor Prognosis.
    Basati G; Mohammadpour H; Emami Razavi A
    J Gastrointest Cancer; 2020 Mar; 51(1):41-47. PubMed ID: 30628031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.
    Paranjape AN; Balaji SA; Mandal T; Krushik EV; Nagaraj P; Mukherjee G; Rangarajan A
    BMC Cancer; 2014 Oct; 14():785. PubMed ID: 25348805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
    Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
    PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis.
    Enjoji S; Yabe R; Tsuji S; Yoshimura K; Kawasaki H; Sakurai M; Sakai Y; Takenouchi H; Yoshino S; Hazama S; Nagano H; Oshima H; Oshima M; Vitek MP; Matsuura T; Hippo Y; Usui T; Ohama T; Sato K
    Mol Cancer Res; 2018 Mar; 16(3):554-563. PubMed ID: 29330298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STARD13 is positively correlated with good prognosis and enhances 5-FU sensitivity via suppressing cancer stemness in hepatocellular carcinoma cells.
    Gao F; Yu X; Meng R; Wang J; Jia L
    Onco Targets Ther; 2018; 11():5371-5381. PubMed ID: 30214243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of hepatocyte nuclear factor 4γ in gastric carcinoma and its role in cell proliferation and stemness].
    Jia YX; Tang H; Chang ZW; Fan HJ; Guan XY; Qin YR
    Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1164-1169. PubMed ID: 34794218
    [No Abstract]   [Full Text] [Related]  

  • 9. Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties.
    Liu J; Ma L; Xu J; Liu C; Zhang J; Liu J; Chen R; Zhou Y
    Int J Oncol; 2013 Feb; 42(2):453-9. PubMed ID: 23229446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-fluorouracil suppresses stem cell-like properties by inhibiting p38 in pancreatic cancer cell line PANC-1.
    Zhao J; Shi X; Dong C; Liu R; Su L; Cao C
    Folia Histochem Cytobiol; 2022; 60(1):55-65. PubMed ID: 35103981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
    Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
    BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E2F1/2/4 mRNA is associated with immune infiltration and are potential biomarkers for the prognosis of human gastric carcinoma.
    Chen Y; Gong W; Dai W; Jiang H; Xu X
    Transl Cancer Res; 2021 Jun; 10(6):2801-2811. PubMed ID: 35116590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. USP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 protein.
    Ma Y; Fu HL; Wang Z; Huang H; Ni J; Song J; Xia Y; Jin WL; Cui DX
    Oncotarget; 2017 May; 8(20):33329-33342. PubMed ID: 28415621
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Zhu YD; Ba H; Chen J; Zhang M; Li P
    Integr Cancer Ther; 2021; 20():15347354211058168. PubMed ID: 34802261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Potential Therapeutic Target for E2F1 and Prognostic Factors of E2F1/2/3/5/7/8 in Human Gastric Cancer.
    Liu X; Hu C
    Mol Ther Methods Clin Dev; 2020 Sep; 18():824-838. PubMed ID: 32953933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDIT3 modulates cancer stemness in gastric cancer by directly regulating CEBPβ.
    Lin H; Liu S; Gao W; Liu H
    J Pharm Pharmacol; 2020 Jun; 72(6):807-815. PubMed ID: 32189359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-329 regulates the sensitivity of 5-FU in chemotherapy of colorectal cancer by targeting E2F1.
    Yin J; Shen X; Li M; Ni F; Xu L; Lu H
    Oncol Lett; 2018 Sep; 16(3):3587-3592. PubMed ID: 30127965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 Promotes Cancer Stemness and Oncogenicity in U2OS and MG-63 Osteosarcoma Cells by Upregulating the OPN-STAT3 Pathway.
    Zhang C; Ma K; Li WY
    J Cancer; 2019; 10(26):6511-6525. PubMed ID: 31777581
    [No Abstract]   [Full Text] [Related]  

  • 19. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
    Qiu G; Ma D; Li F; Sun D; Zeng Z
    Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.